Skip to main content
Figure 2 | Allergy, Asthma & Clinical Immunology

Figure 2

From: Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma

Figure 2

Serial FEV 1 (0-12 h) and Standardized FEV 1 AUC 0-12 h at Week 12 (LOCF). AUC = area under the curve; BID = twice daily; DPI = dry powder inhaler; FEV1 = forced expiratory volume in 1 second; FP/S = fluticasone propionate/salmeterol; LOCF = last observation carried forward; MDI = metered-dose inhaler; MF/F = mometasone furoate/formoterol.

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us